Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
128.34
-2.57 (-1.96%)
Nov 2, 2026, 1:34 PM EST - Market open
Halozyme Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $130 | Buy | Reiterates | $130 | +1.29% | Oct 15, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $105 → $130 | Buy | Reiterates | $105 → $130 | +1.29% | Oct 13, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $70 → $78 | Hold | Reiterates | $70 → $78 | -39.22% | Oct 8, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $110 | Buy | Maintains | $110 | -14.29% | Oct 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 → $105 | Buy | Reiterates | $93 → $105 | -18.19% | Aug 7, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $92 → $93 | Buy | Maintains | $92 → $93 | -27.54% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $75 → $95 | Hold | Reiterates | $75 → $95 | -25.98% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $57 | Sell | Maintains | $57 | -55.59% | Jun 15, 2026 |